North Liberty, IA, United States of America

Christopher Anthony Vakulskas

USPTO Granted Patents = 16 

Average Co-Inventor Count = 3.4

ph-index = 2

Forward Citations = 19(Granted Patents)


Company Filing History:


Years Active: 2020-2025

Loading Chart...
16 patents (USPTO):Explore Patents

Title: The Innovations of Christopher Anthony Vakulskas

Introduction

Christopher Anthony Vakulskas is a prominent inventor based in North Liberty, IA (US). He has made significant contributions to the field of biotechnology, holding a total of 15 patents. His work primarily focuses on enhancing DNA cleavage activities and improving reverse transcriptase functionality.

Latest Patents

Among his latest patents is the development of Cas12a mutants with enhanced cleavage activity at non-canonical TTTT protospacer adjacent motifs. This patent describes CAS12A mutants derived from Lachnospiraceae bacterium, which exhibit improved DNA cleavage activities compared to the wild-type enzyme. Another notable patent involves reverse transcriptase mutants with increased activity and thermostability. This disclosure provides insights into Moloney murine leukemia virus (MMLV) reverse transcriptase mutants, detailing suitable amino acid positions for mutagenesis and methods for synthesizing cDNA from RNA templates.

Career Highlights

Christopher is currently employed at Integrated DNA Technologies, Inc., where he continues to innovate and develop new biotechnological solutions. His work has had a profound impact on the field, particularly in the areas of genetic engineering and molecular biology.

Collaborations

He has collaborated with notable colleagues, including Michael Allen Collingwood and Mark Aaron Behlke, contributing to a dynamic research environment that fosters innovation.

Conclusion

Christopher Anthony Vakulskas exemplifies the spirit of innovation in biotechnology through his extensive patent portfolio and collaborative efforts. His contributions are paving the way for advancements in genetic research and applications.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…